Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Celecoxib × Other neoplasm × Clear all

Phase

Phase 2 2 Phase 2/3 1 Phase 1/2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 3 Other neoplasm 1 Head & Neck 1 Gastrointestinal 1 Dermatologic 1

Conditions

Precancerous Conditions 1 Keratosis, Actinic 1

Interventions

Decitabine 4 Busulfan 3 Cyclophosphamide 2 venetoclax 1 fludarabine 1 Paclitaxel 1 Influenza Vaccines 1 Celecoxib 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00027976 2013-08-05

Celecoxib in Preventing Skin Cancer in Patients With Actinic Keratoses

University of Alabama at Birmingham

Phase 2/3 Withdrawn

DermatologicOther neoplasm

Precancerous Conditions, Keratosis, Actinic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡